Mast Cell Activation Syndrome (MCAS)
July 26, 2022
Bateman Horne Center has partnered with the University of Utah Health to conduct a Long COVID and Post-Viral Syndromes ECHO (Project ECHO). This series delivers information to healthcare professionals utilizing short didactics and case-based learning to enhance their ability to manage patients with long COVID, ME/CFS, FM, and related comorbid conditions.
Brayden Yellman, MD, addresses the assessment & management of mast cell activation syndrome (MCAS):
- Review of mast cells and their function
- Mast cell mediators and associated symptoms
- Mast cell activation/hypersensitivity triggers
- Symptoms of MCAS
- Clinical criteria for MCAS
- Relevance of MCAS to Long COVID and/or ME/CFS
- MCAS treatments
Note to community members: We advise viewers to always speak with their medical care team prior to making any adjustments or changes to their current regimen.
Bateman Horne Centerโs involvement in this program is made possible with the additional support of the Open Medicine Foundation.
-
Category
No comments found